IFABP,小腸型脂肪酸結(jié)合蛋白抗原相關(guān)產(chǎn)品：
Anti-MCP-2/CCL8(Monocyte chemotactic protein 2)rat,mouse 單核細(xì)胞趨化蛋白2抗體(大、小鼠)
Anti-MCP-3/CCL7(Monocyte chemotactic protein 3)human 單核細(xì)胞趨化蛋白3抗體(人)
Anti-MCP-3/CCL7(Monocyte chemotactic protein 3)(rat,mouse) 單核細(xì)胞趨化蛋白3抗體(大、小鼠)
Anti-CCL9/CCL10/MIP-1 gamma（Macrophage inflammatory protein 1-gamma） 巨噬細(xì)胞炎癥蛋白-1γ抗體
Anti-MC-1R (melanocortin-1-receptor) 黑皮質(zhì)素-1受體抗體
Anti-MCT1(monocarboxylate transporter 1) 單羧酸轉(zhuǎn)運(yùn)蛋白-1抗體
Anti-MCM2(minichromosome maintenance protein 2) 微小染色體維持缺陷蛋白2抗體
Anti-MCM3(minichromosome maintenance deficient 3) 微小染色體維持缺陷蛋白3抗體
Anti-MCM7(minichromosome maintenance protein 7) 微小染色體維持缺陷蛋白7抗體
Anti-M-CSF (Macrophage Colony Stimulating Factors) 巨噬細(xì)胞克隆刺激因子抗體
IFABP,小腸型脂肪酸結(jié)合蛋白抗原產(chǎn)品詳情：
英文名稱：IFABP(Intestinal Fatty acid binding protein) Peptide
中文名稱：小腸型脂肪酸結(jié)合蛋白抗原
產(chǎn)品編號：byk-0898P
規(guī) 格：0.5mg
多肽活性：
產(chǎn)品來源：
分 類：
偶聯(lián)蛋白：
純化方法：
儲 存 液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
其他優(yōu)質(zhì)產(chǎn)品：
小鼠β葡糖苷酶(β-glucosidase)試劑盒說明書，96T/48T代測
小鼠β萘酚(β-naphthol)試劑盒說明書，96T/48T代測
小鼠β內(nèi)酰胺酶抑制劑(BLI)試劑盒說明書，96T/48T代測
小鼠β甘露糖苷酶(β Manase)試劑盒說明書，96T/48T代測
小鼠β半乳糖苷酶(βGAL)試劑盒說明書，96T/48T代測
小鼠β氨基己糖苷酶A(β-hexosaminidase A)試劑盒說明書，96T/48T代測
小鼠α半乳糖基抗體(Gal)試劑盒說明書，96T/48T代測
小鼠中性粒細(xì)胞彈性蛋白酶(NE)試劑盒說明書，96T/48T代測
小鼠α羥基丁酸脫氫酶(αHBDH)試劑盒說明書，96T/48T代測
小鼠α甘露糖苷酶(α Manase)試劑盒說明書，96T/48T代測
保存條件：Store at -20 °C for one year. The lyophilized powder is stable at room temperature for at least one month and for greater than a year when kept at -20°C. Upon reconstituted, aliquot and store at -20°C or -80°C. Avoid repeated freeze/thaw cycles.
產(chǎn)品介紹：Serine protease that shows proteolytic activity against a non-specific substrate beta-casein. Promotes or induces cell death either by direct binding to and inhibition of BIRC proteins(also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity, or by a BIRC inhibition-independent, caspase-independent and serine protease activity-dependent mechanism. Isoform 2 seems to be proteolytically inactive. [CATALYTIC ACTIVITY] Cleavage of non-polar aliphatic amino-acids at the P1 position, with a preference for Val, Ile and Met. At the P2 and P3 positions, Arg is selected most strongly with a secondary preference for other hydrophilic residues. [SUBUNIT] Homotrimer. Interacts with MXI2. The mature protein, but not the precursor, binds to BIRC2, BIRC3 and XIAP
會員1.png)
